How did you become a scientist?
When I was in the third grade, I had a science teacher who constantly talked about the marvels of organic chemistry by its isolation, structural analysis and synthesis leading to new and useful drugs from natural products. His presentations invoked curiosity and interest in me. During my early educational career, I looked forward to the discovery and synthesis of new medicinal compounds and hoped to be a participant in this important field. After my bachelor's degree, I joined a masters and Ph.D. program in organic chemistry at Delhi University in India. The project I worked on was to extract and identify compounds from a wood known to be insect resistant and send the compounds for testing as insecticides. I completed my Ph.D. degree in 1955, at age 23, and going through literature was impressed by the biological and medicinal potential of newly discovered synthetic steroid hormones. So I went to Oxford University in England, in October 1956, for a postdoctoral fellowship with Dr Ian Bush in the area of steroid hormones. At Oxford University, I was encouraged to enroll for their D.Phil. program as a successful outcome was dependent on the research done in the laboratory without any other course work. My research went very well and after submitting a dissertation and defending my research conclusions I was awarded a D. Phil from Oxford University in June 1958.
When did you first become interested in reproductive biology and why?
When I was at Oxford, the major research problem I investigated was to resolve the controversy over whether cortisone or cortisol was the biologically active hormone. The difference between the two was that cortisone had an 11-ketone group and cortisol had an 11-beta hydroxyl group. Using commercially available steroids and synthesizing 11-keto and 11-hydroxyl steroid metabolites and working out detailed methods for the measurement of metabolites of these compounds in urine, I was able to show that cortisol was the active glucocorticosteroid and the compound did not undergo metabolism to be biologically active. This work preceded that of Dr Elwood Jensen showing the same thing for estradiol and ultimately lead to the concept of steroid hormone receptors.
While I was working in the Department of the Regius Professor of Medicine at Oxford University, there was a female patient admitted who had developed a sudden onset of hirsutism. With the method of measuring steroids in blood and urine that I had developed, I was able to demonstrate excessive production of androgens in urine as well as adrenal vein blood. When I moved to the Medical College of Georgia, Augusta, GA, in 1959, I had the opportunity to measure steroids from ovarian wedges from patients with polycystic ovaries and hirsutism. Since the partial removal of ovarian wedges from patients with polycystic ovaries, was then, the standard method of management of such patients, Dr Robert Greenblatt, with informed consent from the patient, was able to provide these wedges to me for study. At that time, it was known that the ovary secreted estrogens, but the biosynthetic pathway that it was derived from androgens had not been established. Thus, study of ovarian physiology became a lifetime goal for me.
Who were past scientists and mentors who inspired your research and influenced your career path?
Dr Ian E. Bush in the Department of the Regius Professor of Medicine at Oxford University, England, was my postdoctoral mentor, and he introduced me to some of the methods he had developed for measuring steroid hormones by paper chromatography. I developed these methods further to accomplish the goals of my research.
Dr Robert Greenblatt invited me to join his Department of Endocrinology as Assistant Research Professor in November 1959 and provided me the human polycystic ovarian tissue from hirsute patients. The presence of large quantities of androgens in some ovaries was an extraordinary observation in the very early 1960s. Work in collaboration with Dr Greenblatt also resulted in the discovery that clomiphene citrate could induce ovulation in anovulatory women. Using the trade name Clomid, this drug is usually the first line of treatment given to women with ovulatory failure. The discovery that human polycystic ovaries could alter gonadotropin secretion led to the question as to whether there was an inherent defect in the hypothalamic-pituitary axis or the disruption was caused by ovarian androgens. In an attempt to answer this question, I developed an animal model in which giving a weak androgen to normal rats caused ovulatory failure and disruption of gonadotropin secretion, and androgen withdrawal resulted in restoration of ovulatory function. Although this model did not answer the question as to how excessive androgens in the ovary occurred in the first place, insulin resistance and the influence of insulin on the hyper-responsiveness of the theca cells to LH in androgen production was a very good possibility. The model nevertheless established that androgens could cause abnormal steroid-gonadotropin feedback. These observations led to detailed investigations of steroid-gonadotropin feedback in subsequent studies.
Looking back, what are the one or two decisions you made during your career that had the most impact?
The move to Oxford to study the effects of steroid hormones and joining the Department of Endocrinology at the Medical College of Georgia were two vital moves that guided the direction of my research.
How were you introduced to the SSR and how important was participation in scientific societies to your career development?
The first paper I published in Biology of Reproduction was in 1970 and shortly afterwards I attended the annual meetings of the SSR. I was impressed by the number of papers and symposia presented in the annual meeting that were relevant to my research interests. I joined the SSR as an active member and am still an active member for over 40 years. I have been an active member of many scientific societies in addition to SSR such as The American Physiological Society and the Endocrine Society. My closest association is with the SSR, however.
In the 1970s, membership of scientific societies was of utmost importance because there was no internet and research publications appeared 6 to 8 months after they were submitted. Thus, papers and symposia presented at scientific meetings were essential to keep one up to date with current trends in research. At the current time, in spite of the internet and more rapid publications, state-of-the -art symposia and workshops keep a scientist up to date with progress in related fields that may help provide new approaches to research in their laboratory. In addition, the scientific meetings provide a forum for interaction with leading investigators in the field and orientation in grant writing skills. Also, very important in joining a society is the attempt to educate the public and Congress about the importance of scientific research that has an impact on research funding.
My other interaction with the SSR was that I served as Editorin-Chief of Biology of Reproduction from 1999 to 2004. When I took over the editorship, research manuscripts were submitted by mail and the scientific review also involved transmission by mail. The authors received the first decision in 4 to 6 weeks after submission. I started the process of scanning the submitted manuscripts and sending them to reviewers by e-mail. I also encouraged authors to submit manuscripts by e-mail. These changes were introduced before commercial manuscript review systems were available and the first response time to the author became an average 21 days. 
What is the most important scientific accomplishment that you think you have made so far?
I have made several important observations that are of significant importance in reproductive biology and it is difficult to pick one. The isolation of androgens from the polycystic ovary and the effect of androgens in altering the gonadotropin feedback have already been mentioned. Those findings led to a detailed study of steroidgonadotropin feedback.
Work with adult female rats confirmed that after ovariectomy, estradiol can trigger gonadotropin release. However, the gonadotropin release was less than 10% of that found at proestrus. Injecting a small amount of progesterone caused a gonadotropin surge comparable to that found at proestrus. Using immature female rats, it was demonstrated that estrogen priming in low doses, enough to synthesize progesterone receptors, but not cause an estrogen-induced gonadotropin surge, progesterone caused a gonadotropin surge comparable to that found at proestrus. The mechanism appeared to be secretion of GnRH by the hypothalamus, slowing the degradation of GnRH and reducing estrogen receptors in the hypothalamus.
I have used the term gonadotropin surge as progesterone induced both an LH and FSH surge. Using the immature female rat low-dose estrogen primed model, it was shown that 5-alpha dihydro-progesterone selectively released FSH whereas 3-alpha,5-alpha tetrahydro progesterone selectively released LH. The former used the progesterone receptor, while the latter used the GABA A receptor. Using a 5-alpha reduction blocking agent, it was shown that progesterone under those conditions released only LH but no FSH. Thus, 5-alpha reduction of progesterone was essential for FSH release. These observations are very significant in understanding the steroid control of gonadotropin secretion.
After all this work was done, the discovery that the GnRH neuron did not contain steroid receptors provided a new challenge to find hypothalamic neurons that contain steroid receptors and in turn regulated the GnRH neuron. The steroid-induced gonadotropin surge was blocked by the inhibition of the excitatory amino acid glutamate by its antagonist MK801. In the pregnant mare serum gonadotropintreated immature rat, the administration of the glutamate antagonist reduced serum LH and FSH and the number of ova was ovulated. The administration of the excitatory amino acid agonist NMDA to estrogen-primed rats brought about a rapid release of LHRH in basal hypothalamus/preoptic area fragments and an increase in serum LH and FSH. It was further shown that the hypothalamus secreted glutamate and aspartate during the progesterone-induced gonadotropin surge in estrogen-primed rats.
The mechanism by which progesterone brought about a release of LHRH is by increasing the amount of glutamate secretion and decreasing the inhibitory influence of GABA. This is done by the suppression by progesterone of glutamic acid decarboxylase-67 (GAD67) which results in more glutamate for release and less GABA. In addition, the synaptic terminals' apposition to the GnRH neuron of the vascular GABA transporter (VGAT) was decreased while the vascular glutamate transporter 2 (VGLUT 2) was increased during the proestrous gonadotropin surge, thus further confirming the role of glutamate in the surge.
Physiochemical localization of NMDAR1-containing neurons showed extensive distribution in the hypothalamus, including the organum vasculosum of the lamina termanalis. This NMDAR1 did not co-localize with the GnRH neuron but surrounded several of them. The NMDAR1-containing neurons surrounding the GNRH neuron co-localized NOS-1 activity. Central administration of an NOS inhibitor abolished the steroid-induced gonadotropin surge indicating that NMDA worked through NO in the release of LHRH. The above observations explain the fact that the GnRH neuron responds to estrogen and progesterone action in the absence of steroid receptors in the GnRH neuron. The GnRH neuron is regulated by glutamate-containing neurons that possess steroid receptors. These glutamate receptors then induce NO synthesis which diffuses into the GnRH neuron to bring gonadotropin release.
Naloxone, an opioid antagonist, is known to bring about LH release by blocking the opioid effect. Naloxone increases the NOS activity in the preoptic area due to increased glutamate secretion. This glutamate release is readily blocked by the NMDA antagonist MK801 indicating that the LH-releasing activity of naloxone was mediated by glutamate. Microdialysis experiments showed a significant increase in glutamate secretion within 15 min of naloxone administration.
The neuroprotective effect of estrogens was confirmed, and it was shown that estrogen action on the astrocytes led to the stimulation of TGF-β which was neuroprotective. This was one of the important mechanisms of neuroprotection by estrogens.
The work described above is in very brief detail. It was published in an invited perspective entitled "Hirsutism, virilism, polycystic ovarian disease, and the steroid-gonadotropin -feedback: A career Retrospective" Am. J. Physiol. Endocrinol. Metab. 302 E4-E18, 2012 by Virendra B. Mahesh with complete details and literature citations.
What has been your philosophy in training and mentoring young scientists?
In addition to the responsibility of professors in higher institutions of learning in looking after the career building of students, I have always felt strongly that the future of scientific research and enhancement of my own contributions depended on well-trained young scientists.
When I was a member of the academic advisory committee of each of the other candidates as well and made sure that they had the resources for their research and presenting papers at scientific meetings. Overall, our trainees joined prestigious scientific institutions in the USA and around the world and have made an outstanding contribution to the progress of scientific research. Sixteen of our Ph.D. students received the Distinguished Alumnus Award from the School of Graduate Studies, a number that is close to about 50% of all awards from the Graduate School thus far.
In dealing with graduate students, the most difficult time in their career is when they transform from a worker in the laboratory to being an original thinker and scientist. This transition calls for an individual blend of challenge and nurturing based upon the individual student's need. An important part of establishing scientific recognition is the publication of first authored scientific research. In my career, I have published 471 research papers and book chapters. Over 90% of those have a graduate student or trainee as an author and most as the first author. The first authorship does not come easily. It comes from guiding the student in the right direction which results in excellent work done by the trainee to merit being a first author.
My interest in the career development of young scientists goes beyond my students. What do you consider the greatest breakthroughs in the field of reproductive biology and why?
In my opinion, the introduction of molecular biology to study the gene regulation and mechanism of action of various processes of reproduction has been the greatest breakthrough. It has resulted in making reproductive regulation less descriptive and more mechanistic.
Why do you consider service to your scientific community so important?
In my formative years, attending and becoming a member of a scientific society nurtured my academic growth and research potential. I believe it is important for us to provide the same rich environment to the younger generation of scientists. Equally important are the attempts of the scientific community to inform and educate fellow citizens and congress about the important contribution that scientific research is providing to influence research funding that enables us to do our research.
Would you enter this career again?
I started a scientific career by choice because of the interest evoked in me for science in early education. Being trained as an organic chemist and then in biological sciences gave me a unique opportunity to work at the interface of two disciplines as well as application of the knowledge in addressing human disease. My interaction with young scientists has been one of the highlights of my career. I am a strong believer that what I did in research and education was what was needed by my job as an educator. It is the success of my students, their independent contributions, and their contributions to my research that have brought me recognition. I was fortunate enough to be funded for my research by NIH for 40 years. I could not ask for anything better. So my answer to your question is a resounding YES.
